| 5 mins | 30 mins | Hourly | Daily | Weekly |
|---|---|---|---|---|
| BUY | BUY | BUY | BUY | BUY |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MA5 | 30.26▲ | 30.08▲ | 30.06▲ | 30.28▲ | 30.04▲ |
| MA10 | 30.12▲ | 29.97▲ | 29.47▲ | 31.41▼ | 27.80▲ |
| MA20 | 30.07▲ | 29.38▲ | 29.21▲ | 30.39▲ | 21.23▲ |
| MA50 | 29.98▲ | 29.33▲ | 30.92▼ | 26.17▲ | N/A |
| MA100 | 29.47▲ | 31.12▼ | 30.98▼ | 20.17▲ | N/A |
| MA200 | 29.25▲ | 30.91▼ | 29.53▲ | N/A | N/A |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MACD | 0.045▲ | 0.140▲ | 0.292▲ | -0.518▼ | 0.995▲ |
| RSI | 73.630▲ | 64.801▲ | 56.270▲ | 55.166▲ | 69.692▲ |
| STOCH | 80.554▲ | 82.592▲ | 92.399▲ | 49.333 | 83.357▲ |
| WILL %R | -11.806▲ | -3.803▲ | -3.047▲ | -51.826 | -17.691▲ |
| CCI | 181.560▲ | 111.789▲ | 113.579▲ | -59.128 | 68.681 |
|
Thursday, November 06, 2025 08:01 AM
First-in-human data from Phase 1 trial of MZE782 support best- and first-in-class potential; two Phase 2 proof-of-concept trials in ...
|
|
Thursday, November 06, 2025 04:07 AM
Maze Therapeutics, Inc. (Nasdaq: MAZE), a clinical-stage biopharmaceutical company developing small molecule precision medicines for patients with kidney and metabolic diseases, today announced seven ...
|
|
Tuesday, November 04, 2025 04:17 AM
Maze Therapeutics, Inc. (Nasdaq: MAZE), a clinical-stage biopharmaceutical company developing small molecule precision medicines for patients with kidney and metabolic diseases, today announced that ...
|
| date | open | high | low | close | volume |
|---|---|---|---|---|---|
| 10/11/25 | 28.17 | 30.54 | 28.17 | 30.49 | 389,224 |
| 07/11/25 | 29.87 | 30.37 | 27.69 | 28.60 | 333,600 |
| 06/11/25 | 29.99 | 30.30 | 28.46 | 29.63 | 276,063 |
| 05/11/25 | 29.695 | 30.48 | 26.9578 | 30.27 | 662,214 |
| 04/11/25 | 32.97 | 33.695 | 31.47 | 32.42 | 266,642 |
| 03/11/25 | 32.36 | 33.74 | 32.32 | 33.24 | 378,300 |
| 31/10/25 | 33.51 | 33.91 | 32.33 | 32.91 | 176,900 |
| 30/10/25 | 31.17 | 34.29 | 31.17 | 33.22 | 306,033 |
| 29/10/25 | 32.11 | 33.06 | 31.20 | 31.26 | 274,000 |
| 28/10/25 | 31.05 | 32.67 | 30.60 | 32.10 | 301,243 |
|
|
||||
|
|
||||
|
|